NINDS Neuroscience Funding Announcements

Innovative Therapies and Tools for Screenable Disorders in Newborns (R01)

Funding Contact(s): John Porter, Ph.D.
Funding Categories: Neurogenetics

Brief Description:
This Funding Opportunity Announcement (FOA) issued by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), the National Institute of Diabetes and Digestive and Kidney Disease (NIDDK), the National Institute of Neurological Disorders and Stroke (NINDS) and the National Institute on Deafness and Other Communication Disorders (NIDCD) encourages Research Project Grant (R01) applications from institutions/ organizations that propose research relevant to the basic understanding and development of therapeutic interventions for currently screened conditions and “high priority” genetic conditions for which screening could be possible in the near future. In this FOA, a “high priority” condition is one for which the development of an efficacious therapy would make the condition amenable to newborn screening.

Grant Mechanism: R01
NIH Guide: PAR-10-230
Release Date: 2010-07-19
Expiration Date: 2013-09-08